Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

How Green Are Prescriptions? New Data Offer Clues

Researchers provide one of the first estimates of the carbon footprint of primary care prescribing, offering data to support more environmentally sustainable medication use.

EMA Clears One Rare Brain Disease Therapy, Rejects Another

European regulators recommended a treatment for childhood cerebral adrenoleukodystrophy but refused one for Niemann-Pick disease type C.

EU Panel Backs First Refillable Eye Implant for AMD

Susvimo, a refillable ranibizumab implant for neovascular age-related macular degeneration, could reduce treatment burden by replacing monthly injections with 24-week refills.

Oral Cancer Screening Identifies Lesions, Follow-Up Lags

Mobile screening units identify oral mucosal lesions in 1 in 20 individuals in Hungary.

GP Follow-Up Tied to Higher Cervical Surveillance Loss

Patients with cervical precancerous lesions followed by general practitioners showed higher rates of missed surveillance appointments than those monitored by gynecologists.

EMA Recommends New Hematology and Supportive Care Drugs

Ruxolitinib Viatris and Cavoley moved closer to EU approval, offering a bioequivalent option for hematologic disease and a biosimilar to help prevent chemotherapy-related febrile neutropenia.

Todays Updates

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Transperineal Biopsy IDs Active Surveillance Candidates

Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.

The Clues Hidden in Failed Prostate Cancer Trials

Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.

Todays Updates

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Transperineal Biopsy IDs Active Surveillance Candidates

Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.

The Clues Hidden in Failed Prostate Cancer Trials

Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.

Latest News

Researchers provide one of the first estimates of the carbon footprint of primary care prescribing, offering data to support more environmentally sustainable medication use.

European regulators recommended a treatment for childhood cerebral adrenoleukodystrophy but refused one for Niemann-Pick disease type C.

Susvimo, a refillable ranibizumab implant for neovascular age-related macular degeneration, could reduce treatment burden by replacing monthly injections with 24-week refills.

Mobile screening units identify oral mucosal lesions in 1 in 20 individuals in Hungary.

Patients with cervical precancerous lesions followed by general practitioners showed higher rates of missed surveillance appointments than those monitored by gynecologists.

Ruxolitinib Viatris and Cavoley moved closer to EU approval, offering a bioequivalent option for hematologic disease and a biosimilar to help prevent chemotherapy-related febrile neutropenia.

News All Time

Traffic Noise a Novel Parkinson’s Risk Factor?

Long-term exposure to loud traffic noise may be a novel environmental risk factor for Parkinson’s disease, a new study suggests.

Hearing Checks Boost Detection of Cytomegalovirus in Infants

The findings underscore why many experts are still pushing for universal screening.

First MS Mobility Drug Gets Green Light From NHS England

NHS England reverses a 2022 NICE rejection now fampridine is off patent, bringing England into line with the rest of the UK.

Why Oropouche Virus Is Gaining Global Attention

Researchers report rapid spread, widespread underdiagnosis, and growing travel-associated infections, raising concerns about future outbreaks beyond Latin America.

Pharmacies Left Out as Pubs Get Rates Cut

Pharmacy associations criticise the government's decision to offer another business rates cut to pubs and live music venues while excluding high street pharmacies again.

A Blood Test for Colon Cancer Screening? Not So Fast!

Dr Aasma Shaukat says that the convenience of a blood test for colorectal cancer should not outweigh the performance of a blood test, especially when weighed against the other options available.

To Treat or Not to Treat? The COVID Conundrum

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

All Quiet on the Vaccine Front?

While public support for vaccines remains strong, quieter efforts to weaken vaccine policy, compensation programs, and scientific oversight are gaining ground. Here's what physicians need to know.

Both Sides of the Bars: Jail Reform as Mental Health Policy

Jails have become de facto psychiatric institutions. Dr Temitope Ogundare explains why psychiatrists should help prevent incarceration — not just treat its consequences.

The Challenge With Health Data Is Using It Well

An international survey finds physicians are ready to use wearable health data. The bigger challenge is building the systems to turn that information into better care.

Sickle Cell Disease Linked to Higher Postpartum LARC Use

People with sickle cell disease received immediate postpartum long-acting reversible contraception at more than three times the rate of those without the condition, even after adjusting for clinical and demographic factors.

Should Age Trigger Physician Screening? Many Doctors Say No

A Medscape commentary asks whether older physicians should be tested for competence. Readers answer with a question of their own: Why single out age?

Microteams Tied to Better Continuity of Care in Primary Care

Implementation of a microteams model is associated with an increase in consultations with GPs, indicating improved continuity of care.

Parkinson's Care Gaps: Do Immigrant Patients Face Barriers?

Immigrant patients with Parkinson's disease have clinical profiles similar to native patients but are less likely to attend follow-up visits and adhere to treatment, a Spanish study shows.

Indigenous Canadians Face Cancer Survival Inequalities

Breast, colon, and cervical cancer incidence and mortality have improved for First Nations patients, but survival is significantly lower than that of other Ontario residents.

No Vitamin K Shot at Birth May Up Infant Bleeding Risk

Infants who do not receive intramuscular vitamin K prophylaxis at birth have higher odds of bleeding episodes and intracranial hemorrhage during the first 6 months of life.

Recommended News For You

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Q&A: How early cancer screening could save Canada nearly half a billion dollars over patients' lifetimes

Team finds broken 'brake' on cancer mutation machine.

Breast cancer: Why it's difficult to treat and what new approaches are on the horizon

FDA Warns of Secondary Blood Cancer Risk With Tazverik

Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Recommended Articles For You

Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment 

Exploring the Causes and Treatment of Granulocytopenia: A Comprehensive Guide 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Precision Oncology: How Personalized Medicine is Transforming Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

2.

Triplet Could Become a New Standard in Tough-to-Treat CLL

3.

FDA Says First 'Real-Time' Clinical Trial Is Underway

4.

'Sleep ALL night' program helps children with leukemia sleep better during treatment

5.

PSMA PET Beats MRI in Prostate Cancer Staging Study

1.

The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond

2.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

3.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

4.

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies 

5.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

2.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

3.

Should We Use DARA Up Front As First-Line Therapy in MM?

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot